• Something wrong with this record ?

Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases

M. Kwik, S. Hainzl, J. Oppelt, B. Tichy, U. Koller, E. Bernardinelli, M. Steiner, G. Zara, C. Nofziger, S. Weis, M. Paulmichl, S. Dossena, W. Patsch, SM. Soyal

. 2021 ; 22 (7) : . [pub] 20210324

Language English Country Switzerland

Document type Journal Article

Grant support
V344-B24 Austrian Science Fund
E-13/18094_PAT PMU-FFA-14/01/011-SOY Paracelsus Medical University Salzburg

The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1α), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1α isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019011
003      
CZ-PrNML
005      
20240103105128.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22073296 $2 doi
035    __
$a (PubMed)33804860
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kwik, Markus $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
245    10
$a Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases / $c M. Kwik, S. Hainzl, J. Oppelt, B. Tichy, U. Koller, E. Bernardinelli, M. Steiner, G. Zara, C. Nofziger, S. Weis, M. Paulmichl, S. Dossena, W. Patsch, SM. Soyal
520    9_
$a The transcriptional regulator peroxisome proliferator activated receptor gamma coactivator 1A (PGC-1α), encoded by PPARGC1A, has been linked to neurodegenerative diseases. Recently discovered CNS-specific PPARGC1A transcripts are initiated far upstream of the reference promoter, spliced to exon 2 of the reference gene, and are more abundant than reference gene transcripts in post-mortem human brain samples. The proteins translated from the CNS and reference transcripts differ only at their N-terminal regions. To dissect functional differences between CNS-specific isoforms and reference proteins, we used clustered regularly interspaced short palindromic repeats transcriptional activation (CRISPRa) for selective endogenous activation of the CNS or the reference promoters in SH-SY5Y cells. Expression and/or exon usage of the targets was ascertained by RNA sequencing. Compared to controls, more differentially expressed genes were observed after activation of the CNS than the reference gene promoter, while the magnitude of alternative exon usage was comparable between activation of the two promoters. Promoter-selective associations were observed with canonical signaling pathways, mitochondrial and nervous system functions and neurological diseases. The distinct N-terminal as well as the shared downstream regions of PGC-1α isoforms affect the exon usage of numerous genes. Furthermore, associations of risk genes of amyotrophic lateral sclerosis and Parkinson's disease were noted with differentially expressed genes resulting from the activation of the CNS and reference gene promoter, respectively. Thus, CNS-specific isoforms markedly amplify the biological functions of PPARGC1A and CNS-specific isoforms and reference proteins have common, complementary and selective functions relevant for neurodegenerative diseases.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a exony $7 D005091
650    12
$a genové regulační sítě $7 D053263
650    _2
$a HEK293 buňky $7 D057809
650    _2
$a lidé $7 D006801
650    _2
$a neurodegenerativní nemoci $x genetika $7 D019636
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a nukleotidové motivy $7 D059372
650    _2
$a PPARGC1A $x genetika $x metabolismus $7 D000071248
650    12
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a protein - isoformy $x genetika $x metabolismus $7 D020033
650    12
$a aktivace transkripce $7 D015533
650    _2
$a transkriptom $7 D059467
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hainzl, Stefan $u EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria
700    1_
$a Oppelt, Jan $u CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic $u Department of Pathology and Laboratory Medicine, Perlman School of Medicine, University of Pennsylvania, 614 Stellar-Chance Labs, 422 Curie Blvd, Philadelphia, PA 19104-6100, USA
700    1_
$a Tichý, Boris $u CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic $7 xx0312236
700    1_
$a Koller, Ulrich $u EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria
700    1_
$a Bernardinelli, Emanuele $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
700    1_
$a Steiner, Markus $u Third Medical Department, Cancer Research Institute, Paracelsus Medical University, Cancer Cluster Salzburg, 5020 Salzburg, Austria
700    1_
$a Zara, Greta $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
700    1_
$a Nofziger, Charity $u PharmGenetix GmbH, 5081 Niederalm, Austria
700    1_
$a Weis, Serge $u Division of Neuropathology, Neuromed Campus, Kepler University Hospital, 4020 Linz, Austria
700    1_
$a Paulmichl, Markus $u Department of Personalized Medicine, Humanomed, 9020 Klagenfurt, Austria
700    1_
$a Dossena, Silvia $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
700    1_
$a Patsch, Wolfgang $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
700    1_
$a Soyal, Selma M $u Institute of Pharmacology and Toxicology, Paracelsus Medical University, Strubergasse 18, 5020 Salzburg, Austria
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 7 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33804860 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20240103105124 $b ABA008
999    __
$a ok $b bmc $g 1689939 $s 1139457
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 7 $e 20210324 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a V344-B24 $p Austrian Science Fund
GRA    __
$a E-13/18094_PAT PMU-FFA-14/01/011-SOY $p Paracelsus Medical University Salzburg
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...